Prof. Frank Leebeek: About 20 % of People with Von Willebrand’s Disease Have Something Strange Going On
Erasmus MC shared a post on LinkedIn:
“Scientists at Erasmus MC have discovered that Von Willebrand’s blood clotting disease is not always caused by an error in the gene of the same name. A problem in the secretion of the clotting protein can also trigger the disease, they showed.
In people with Von Willebrand disease, something goes wrong in blood clotting. This is usually because their body produces too little or a poorly functioning version of the clotting protein Von Willebrand factor. That protein acts as a kind of band-aid to stop bleeding.
About twenty percent of people with Von Willebrand’s disease have something strange going on. They do not have an error in the Von Willebrand factor gene, but they do have too little clotting protein in their blood. “We have been looking for years to find out what causes the disease in these people,” says hematologist Prof. Frank Leebeek of Erasmus MC. A recent study by the Department of Hematology, published in Blood, points to a new cause.”
Read full paper here.
Stay updated with Hemostasis Today.
-
Feb 17, 2026, 16:34ISTH Names Five Global Recipients of 2026 Esteemed Career Awards
-
Feb 17, 2026, 16:16Flora Peyvandi: A Multicenter Initiative to Improve Guideline Adherence in Pediatric ITP
-
Feb 17, 2026, 16:14Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
-
Feb 17, 2026, 15:42Paul Wischmeyer: Nutrient Absorption in the GI Tract
-
Feb 17, 2026, 15:40Mahesan Subramaniam: Reversing Age-Related Decline in Blood Stem Cells
-
Feb 17, 2026, 15:38Wolfgang Miesbach: How a Single Mutation Can Flip Immunity into VITT
-
Feb 17, 2026, 15:34Jeff June: When Safety Warnings Outlive the Evidence – What Statins Teach Us About Stroke Prevention and Biology
-
Feb 17, 2026, 15:32Gabrielle Sarlon: Key Messages to Improve VTE Management in Women of Childbearing Age
-
Feb 17, 2026, 15:27Piezo1 Gain-of-Function Mutation Explains Thromboembolic Complications in Hereditary Xerocytosis – JTH